# Association between spirochaetal infection and neurodegenerative diseases: a systematic review and quantitative synthesis of observational studies

**Authors:** Mia Horton, Daniel J. Whiley, Megan Mayhew, Samantha McLean

PMC · DOI: 10.1099/jmm.0.002136 · Journal of Medical Microbiology · 2026-03-06

## TL;DR

This study reviews evidence linking spirochaetal infections like syphilis and leptospirosis to neurodegenerative diseases, finding a potential link but mixed results for Lyme disease.

## Contribution

The paper systematically evaluates observational evidence for spirochaetal infections' role in neurodegeneration, highlighting gaps in current research.

## Key findings

- Studies on syphilis and leptospirosis show consistent cognitive impairment and increased dementia risk.
- Lyme disease findings are inconsistent, with some suggesting increased Alzheimer’s risk and others showing no cognitive effects.
- No eligible studies were found for Brachyspira spp., and Treponema denticola was excluded due to confounding factors.

## Abstract

Introduction. Neurodegenerative diseases, including Alzheimer’s and Parkinson’s, are a growing global health concern. While age remains the primary risk factor, infectious agents have been proposed as potential contributors to disease onset or progression.

Gap statement. Spirochaetal bacteria, such as Treponema pallidum, Borrelia burgdorferi and Leptospira spp., can invade the central nervous system, yet the extent to which these infections influence neurodegenerative outcomes remains unclear.

Aim. This systematic review aimed to evaluate observational evidence on the association between spirochaetal infections and neurodegenerative diseases and to identify gaps in the literature to inform future research.

Methodology. A systematic search of SCOPUS, EMBASE, PubMed/MEDLINE, Web of Science and CINAHL was conducted for studies published between January 2000 and May 2025. Eligible studies were observational, involved adult human populations and reported both spirochaetal infection and cognitive or neurodegenerative outcomes using standardized methods. Data were extracted using a standardized form. Owing to heterogeneity in study design, diagnostic approaches, outcome measures and reporting formats, an overall pooled meta-analysis was not feasible; however, a quantitative synthesis using meta-analytic methods was conducted for studies reporting mini-mental state examination data. Risk of bias was assessed using the Newcastle–Ottawa Scale.

Results. Twenty-seven studies met the inclusion criteria: 13 on T. pallidum, 13 on B. burgdorferi and one on Leptospira spp. No eligible studies were found for Brachyspira spp., and studies involving Treponema denticola were excluded due to confounding by periodontitis. Studies investigating syphilis and leptospirosis consistently reported cognitive impairment and increased dementia risk. In contrast, findings for Lyme disease were heterogeneous, with some studies reporting persistent symptoms or increased Alzheimer’s risk, while others found no long-term cognitive effects.

Conclusion. This review highlights a potential link between spirochaetal infections and neurodegenerative outcomes, particularly for syphilis and leptospirosis. Evidence for Lyme disease remains inconclusive. Future research should prioritize longitudinal studies with standardized diagnostic criteria, integration of neuroimaging and biomarker data and improved diagnostic accuracy for spirochaetal infections.

## Linked entities

- **Diseases:** dementia (MONDO:0001627), syphilis (MONDO:0005976), leptospirosis (MONDO:0005825), Lyme disease (MONDO:0019632)
- **Species:** Treponema pallidum (taxon 160), Treponema denticola (taxon 158)

## Full-text entities

- **Genes:** NRGN (neurogranin) [NCBI Gene 4900] {aka RC3, hng}, CSF2 (colony stimulating factor 2) [NCBI Gene 1437] {aka CSF, GMCSF}, APOA1 (apolipoprotein A1) [NCBI Gene 335] {aka AMYLD3, HPALP2, apo(a)}, BACE1 (beta-secretase 1) [NCBI Gene 23621] {aka ASP2, BACE, HSPC104}, MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}, CXCL13 (C-X-C motif chemokine ligand 13) [NCBI Gene 10563] {aka ANGIE, ANGIE2, BCA-1, BCA1, BLC, BLR1L}, APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}, NOS1 (nitric oxide synthase 1) [NCBI Gene 4842] {aka IHPS1, N-NOS, NC-NOS, NOS, bNOS, nNOS}
- **Diseases:** GP (OMIM:614201), periodontal disease (MESH:D010510), FTD (MESH:D057180), fungal (MESH:D009181), neuroaxonal injury (MESH:D019150), multiple sclerosis (MESH:D009103), memory difficulties (MESH:D008569), Cognitive impairment (MESH:D003072), neurological sequelae (MESH:D009422), disability (MESH:D009069), Neurological and Communicative Disorders (MESH:D003147), depression (MESH:D003866), impaired social, emotional and physical functioning (OMIM:300082), amyloid (MESH:C000718787), Dementia (MESH:D003704), parkinsonism (MESH:D010302), post- (MESH:D000094025), T. pallidum infection (MESH:D007239), CSF pleocytosis (MESH:D007964), paresis (MESH:D010291), cerebrovascular disease (MESH:D002561), erythema migrans (MESH:D005929), demyelinating diseases (MESH:D003711), frontal syndromes in addition to psychosis and psychomotor syndromes. Frontal lobe syndrome (MESH:D001927), delusions (MESH:D063726), Lyme Neuroborreliosis (MESH:D020852), neurologic abnormalities (MESH:D009461), MDD (MESH:D003865), olfactory dysfunction (MESH:D000857), frontal hypometabolism (MESH:D020233), motor neuron diseases (MESH:D016472), impairments in language fluency (MESH:D007806), Stroke (MESH:D020521), NS (MESH:D056770), neurological and functional impairments (MESH:D003291), cognitive symptoms (MESH:D019954), fatigue (MESH:D005221), Neurosyphilis (MESH:D009494), Guillain-Barre syndrome (MESH:D020275), medial temporal lobe (MESH:D004833), Mental Disorders (MESH:D001523), brain atrophy (MESH:C566985), AD (MESH:D000544), B. burgdorferi infection (MESH:D008193), Lewy body disease (MESH:D020961), Atrophy (MESH:D001284), neuroinflammation (MESH:D000090862), leptospirosis (MESH:D007922), GPI (MESH:C537277), Syphilis (MESH:D013587), Neurodegenerative diseases (MESH:D019636), inflammation (MESH:D007249), parkinsonian syndromes (MESH:D020734), periodontitis (MESH:D010518), Parkinson's (MESH:D010300), grey matter loss (MESH:D055652), pain (MESH:D010146)
- **Chemicals:** beta-lactams (MESH:D047090), homocysteine (MESH:D006710), N-acetylaspartate (MESH:C000179), cephalosporins (MESH:D002511), creatine (MESH:D003401), fluorodeoxyglucose (MESH:D019788), LNB (-), Penicillin (MESH:D010406), cholesterol (MESH:D002784), choline (MESH:D002794), doxycycline (MESH:D004318)
- **Species:** Treponema pallidum (species) [taxon 160], Borrelia sp. (species) [taxon 145], Spirochaetia (class) [taxon 203692], Homo sapiens (human, species) [taxon 9606], Porphyromonas gingivalis (species) [taxon 837], Chlamydia pneumoniae (species) [taxon 83558], Human alphaherpesvirus 1 (Herpes simplex virus type 1, no rank) [taxon 10298], Treponema denticola (species) [taxon 158], Borreliella burgdorferi (Lyme disease spirochete, species) [taxon 139]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12967094/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12967094/full.md

## References

77 references — full list in the complete paper: https://tomesphere.com/paper/PMC12967094/full.md

---
Source: https://tomesphere.com/paper/PMC12967094